Psilocybin-Assisted Therapy for Intergenerational Trauma
Status:
RECRUITING
Trial end date:
2030-01-02
Target enrollment:
Participant gender:
Summary
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders.
The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.